The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09I | Tumour detection | |
| 4 | V09IX | Other diagnostic radiopharmaceuticals for tumour detection | |
| 5 | V09IX04 | Fludeoxyglucose (18F) |
| Active Ingredient | Description | |
|---|---|---|
| Fludeoxyglucose ¹⁸F |
Fludeoxyglucose F18 is a glucose analog that concentrates in cells that rely upon glucose as an energy source, or in cells whose dependence on glucose increases under pathophysiological conditions. Fludeoxyglucose F18 is used to assess glucose metabolism. It is a positron emitting radiopharmaceutical that is used for diagnostic purposes in conjunction with positron emission tomography (PET) imaging. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| GLUSCAN Solution for injection | Web Search | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
